期刊文献+

小鼠BTLA慢病毒表达载体的构建及鉴定

Construction and identification of mouse BTLA lentiviral expression vector
下载PDF
导出
摘要 目的构建小鼠BTLA慢病毒表达载体,并对表达产物进行鉴定。方法以pET-28a-mBTLA质粒为模板,通过PCR技术构建pMD18-T-mBTLA质粒,将小鼠BTLA基因全长编码序列克隆到慢病毒转移载体,通过脂质体转染293T细胞包装成小鼠BTLA慢病毒颗粒。PCR技术和基因测序对重组质粒进行鉴定。荧光显微镜观察重组慢病毒感染293T细胞形态学变化。RT-PCR和Western blot法鉴定BTLA在重组慢病毒感染293T细胞中的表达。50%组织培养感染剂量法(TCID50法)检测重组慢病毒滴度。结果成功构建的pMD18-T-mBTLA质粒和pSL6-mBTLA质粒,经双酶切电泳后均出现大小约为1 kb的条带与mB-TLA编码序列的大小相符。基因测序并比对分析进一步证实mBTLA编码序列成功整合到质粒载体。病毒上清PCR扩增和293T细胞形态学观察证实Lenti-mBTLA慢病毒包装成功。TCID50法测定Lenti-mBTLA慢病毒滴度为1.3×108pfu/mL。RT-PCR和Western blot法证实Lenti-mBTLA慢病毒能有效表达mBTLA mRNA和蛋白质。结论成功构建了表达小鼠BTLA的慢病毒。 Objective To construct and identify a lentiviral vector for mBTLA ( mouse B and T lymphocyte attenuator) expression. Methods The entire coding sequence of mBTLA gene was amplified from pET-28a-mBTLA plasmid, and then mBTLA gene was transferred into pMDlS-T plasmid before cloning into a lentiviral transfer vector. Liposome was used to package lentiviral particles in 293T cells. After lentiviral particles packaging, morphological changes of 293T cells were observed by fluorescence microscope. The recombinant plasmid was identified using RT-PCR and sequencing. Lentiviral titer was detected by 50% tissue culture infectious dose ( TCIDso ) assay. RT-PCR and Western blotting were used to detect mBTLA mRNA and protein expression. Results pMD18-T-mBTLA and pSL6-mBTLA plasmids were successfully constructed and digested for electrophoresis appearing a near 1 kb strip which matched the size of mBTLA coding sequence. Gene se- quencing and alignment analysis further confirmed mBTLA coding sequence to be successfully integrated into the plasmid vector. Morphological observation and supernatant PCR amplification of 293T cells confirmed that Lenti-mBTLA lentiviral packaging was successful, and the Lenti-mBTLA lentiviral titer was 1.3 x 108. pfu/mL. RT-PCR and Western blotting demon- strated that the Lenti-mBTLA vector could effectively express mBTLA mRNA and protein. Conclusion The lentiviral vector which can effectively express mBTLA mRNA and protein has been successfully constructed.
出处 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2013年第3期261-264,共4页 Chinese Journal of Cellular and Molecular Immunology
基金 国家自然科学基金(30971779 81273237) 广东省科技计划项目(2009B030801333) 广东医学院青年科学基金项目(XQ1124)
关键词 慢病毒 B、T淋巴细胞弱化因子 293T细胞 PCR技术 lentivirus B and T lymphocyte attenuator 293T cells PCR analysis
  • 相关文献

参考文献15

  • 1Hurchla MA, Sedy JR, Gavrieli M, et al. B and T lymphocyte attenuator exhibits structural and expression polymorphisms and is highly Induced in anergic CD4^+ T cells[J]. J Immunol, 2005, 174(6): 3377 - 3385.
  • 2Han P, Goularte OD, Rufner K, et al. An inhibitory Ig superfamily protein expressed by lymphocytes and APCs is also an early marker of thymocyte positive selection[ J ]. J Immunol, 2004, 172 (10) : 5931 - 5939.
  • 3Steinberg MW, Cheung TC, Ware CF. The signaling networks of the herpesvinls entry mediator ( TNFRSFI4 ) in immune regulation [ J]. Immunol Rev, 2011, 244( 1 ) : 169 - 187.
  • 4Ware CF, Sedy, JR. TNF Superfamily Networks: bidirectional and interference pathways of the herpesvirus entry mediator (TNFSF14) [J]. Curr Opin Immunol, 2011, 23(5) : 627 -631.
  • 5Cai G, Freeman GJ. The CDI60, BTLA, LIGHT/HVEM pathway: a bidirectional switch regulating T-cell activation [ J ]. lmmunol Rev, 2009, 229( 1 ) : 244 -258.
  • 6De Trez C, Schneider K, Potter K, et al. The inhibitory HVEM-BTLA pathway counter regulates lymphotoxin ~ceptor signaling to achieve homeostasis of dendritic cells[ J]. J Immunol, 2008, 180( 1 ) : 238 - 248.
  • 7Paulos CM, June CH. Putting the brakes on BTLA in T cell-mediated cancer immunotherapy[ J]. J Clin Invest, 2010, 120(1) : 76 -80.
  • 8Lasaro MO, Sazanovich M, Giles-Davis W, et al. Active immunother- apy combined with blockade of a coinhibitory pathway achieves regres- sion of large tumor masses in cancer-prone mice[ J]. Mol Ther, 2011, 19(9) : 1727 - 1736.
  • 9Shang Y, Guo G, Cui Q, et al. The expression and anatomical distri- bution of BTLA and its ligand HVEM in rheumatoid synovium [ J]. Inflammation, 2012, 35 ( 3 ) : 1102 - 1112.
  • 10Oya Y, Watanabe N, Kobayashi Y, et al. Lack of B and T lympho- cyte attenuator exacerbates autoimmune disorders and induces Fas-in- dependent liver injury in MRL-lpr/lpr mice[ J]. Int hnmunol, 2011, 23(5) : 335 -344.

二级参考文献9

  • 1费世江,吴雄文,翁秀芳,蔡蕾,梁智辉,韩军艳,龚非力.预先形成的重链二硫键有助于HLA-A2-抗原肽复合物体外折叠[J].细胞与分子免疫学杂志,2005,21(2):167-170. 被引量:1
  • 2Watanabe N,Gavrieli M,Sedy JR,et al.BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1[J].Nat Immunol,2003,4(7):670-679.
  • 3Han P,Goularte OD,Rufner K,et al.An inhibitory Ig superfamily protein expressed by lymphocytes and APCs is also an early marker of thymocyte positive selection[J].J Immunol,2004,172(10):5931-5939.
  • 4Sedy JR,Gavrieli M,Potter KG,et al.B and T lymphocyte attenuator regulates T cell activation through interaction with herpesvirus entry mediator[J].Nat Immunol,2005,6(1):90-98.
  • 5Gonzalez LC,Loyet KM,Calemine-Fenaux J,et al.A coreceptor interaction between the CD28 and TNF receptor family members B and T lymphocyte attenuator and herpesvirus entry mediator[J].Proc Natl Acad Sci USA,2005,102(4):1116-1121.
  • 6Shen Z,Reznikoff G,Dranoff G,et al.Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules[J].J Immunol,1997,158(6):2723-2730.
  • 7Wang Y,Subudhi SK,Anders RA,et al.The role of herpesvirus entry mediator as a negative regulator of T cell-mediated responses[J].J Clin Invest,2005,115(3):711-717.
  • 8Compaan DM,Gonzalez LC,Tom I,et al.Attenuating lymphocyte activity:the crystal structure of the BTLA-HVEM complex[J].J Biol Chem,2005,280(47):39553-39561.
  • 9吴东,沈锋,娄永华,焦炳华,吴孟超.人LIGHT基因的克隆及其重组腺病毒载体的构建[J].细胞与分子免疫学杂志,2002,18(2):121-124. 被引量:8

共引文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部